| | | | | THURSDAY, SEPTEMBER 13 - Nagelmackers room - Level 2 |
| | | | | |
| | | | | | 11.20 - 12.30 FAMILIAL AND GENETIC ASPECTS OF AORTIC DISEASES
|
| | | | | JURY: Bart Loeys, Dianna Milewicz |
| 11.20 | | | SMAD2 and SMAD6: two novel genetic players in aortic aneurysm and dissection, Melanie Perik  |
| 11.28 | | | Study of the contribution of copy number variation to the pathogenesis of bicuspid aortic valve associated aortopathy, Ilse Luyckx |
| 11.36 | | | New insights into fibrillinopathies and pitfalls of variant filtering in the current genomics era, Janine Meienberg |
| 11.44 | | | Candidate drug testing in murine models of aortic diseases using biomechanical integrity as novel read-out,
Nicolo Dubacher |
| 11.52 | | | MicroRNA-574-5p: a circulating marker of thoracic aortic aneurysm, Adeline Boileau |
| | 12.00 | | | Gene expression in patients with abdominal aortic aneurysm - more than immunological mechanisms involved, Miroslav Prucha |
| | 12.08 | | | Aortic microcalcification is associated with aortopathy in Marfan Syndrome; potential marker for imaging,
Vivian de Waard |
| | | | | |
| | | | | | 16.00 - 18.00 NEW INSIGHTS INTO AORTIC PATHOLOGY AND MANAGEMENT |
| | | | | JURY: Marc Bailey, Nicos Labropoulos, Lars Maegdefessel |
| | 16.00 | | | Plasminogen activator inhibitor type 1 promote experimental aortic dissection in mice, Yasunori Iida |
| | 16.10 | | | Abdominal aortic aneurysm and IgG4-associated disease, Miroslav Prucha |
| | 16.20 | | | Patients with abdominal aortic aneurysm demonstrate higher levels of non-cholesterol sterol markers of endogenous cholesterol synthesis, Miroslav Prucha |
| | 16.30 | | | Modeling tissue re-modeling during the pathogenesis of abdominal aortic aneurysms, Tina Cohnert |
| | 16.40 | | | Leukotriene B4 plasma levels are associated to AAA prevalence and progression, Mónica M. Torres-Fonseca |
| | 16.50 | | | Investigating the influence of aortic composition on predisposition of aneurysmal disease, Lakmini Liyanage |
| | 17.00 | | | Endovascular treatment of abdominal aortic aneurysm: impact of diabetes on endoleaks and reintervention, Charlotte Praca |
| | 17.10 | | | Wall-layer-specific transcriptome and finite element analysis-derived rupture risk in abdominal aortic aneurysms, Moritz Lindquist Liljeqvist |
| | 17.20 | | | The new adominal aortic stent graft- personal experience with ovation and aorfix stent graft, Stevo Duvnjak |
| | 17.30 | | | Hybrid approach for aortic arch diseases: single center experience, Vitalii Kravchenko
|
| | 17.40 | | | Aneurysms – as complication after coarctation of the aorta correction. Frequency, methods and result of treatment, Yurii Tarasenko |
| | 17.50 | | | Outcomes of aortic surgery in a tertiary care hospital: our experience |
| | 18.00 | | | Treatment of blunt aortic isthmus rupture : 16-year single center experience, Pierre-Arnaud Wuidar |
| | | | | |
| | | | | E-POSTERS TO BE PRESENTED IN THE MAIN SESSION |
| | | | | |
| | | | | | WEDNESDAY, SEPTEMBER 12 |
| | 18.10 | | | Back to basics – Increasing the use of posteroanterior chestradiograph to aid assessment of chest pain for aortic dissection, Sachintha Perera |
| | | | | |
| | | | | | THURSDAY, SEPTEMBER 13 |
| | 18.48 | | | The images behind intramural haematoma, Andreas Mitsis |
| | | | | |
| | | | | | FRIDAY, SEPTEMBER 14 |
| | 09.18 | | | Blood glucose, diabetes and abdominal aortic aneurysm among 2 million screened individuals, Dylan Morris |
| | 09.22 | | | Should we screen women for abdominal aortic aneurysm? Ulug Pinar |
| | 09.26 | | | The TAGA study: a new family study for the genetic analysis of aortic abdominal aneurysm, Maria Sabater-Lleal |
| | 11.55 | | | Final findings of the Fenofibrate in the management of AbdoMinal aortic aneurysm (FAME)-2 trial, Joseph Moxon |
| | | | | |
| | | | | |
